1. Home
  2. BWAY vs NPCE Comparison

BWAY vs NPCE Comparison

Compare BWAY & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$15.21

Market Cap

674.2M

Sector

Health Care

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.11

Market Cap

623.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWAY
NPCE
Founded
2003
1997
Country
Israel
United States
Employees
129
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
674.2M
623.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BWAY
NPCE
Price
$15.21
$15.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$13.25
$18.33
AVG Volume (30 Days)
127.0K
196.7K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
$309.69
$0.90
Revenue Next Year
$26.21
$24.46
P/E Ratio
$81.98
N/A
Revenue Growth
N/A
25.13
52 Week Low
$9.98
$7.56
52 Week High
$26.63
$19.60

Technical Indicators

Market Signals
Indicator
BWAY
NPCE
Relative Strength Index (RSI) 42.28 41.67
Support Level $14.56 $12.52
Resistance Level $16.63 $17.04
Average True Range (ATR) 0.65 1.17
MACD -0.11 -0.34
Stochastic Oscillator 13.24 24.54

Price Performance

Historical Comparison
BWAY
NPCE

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: